Amphastar Pharmaceuticals (AMPH) Profit After Tax (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Profit After Tax of $6.4 million for Q1 2026, down 74.61% year-over-year from $25.3 million in Q1 2025, and down 73.72% quarter-over-quarter from $24.4 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Profit After Tax (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Profit After Tax history runs 14 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 74.61% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $79.2 million (down 43.83% YoY), while the FY2025 annual figure was $98.1 million, down 38.51% from the prior year.
- Profit After Tax for Q1 2026 stood at $6.4 million, down from $24.4 million in the prior quarter.
- The five-year high for Profit After Tax was $49.6 million in Q3 2023, with the low at $6.4 million in Q1 2026.
- The 5-year median for Profit After Tax is $26.1 million (2023), against an average of $29.2 million.
- The sharpest annual moves came in 2022 and 2026: Profit After Tax jumped 381.11% in 2022, then sank 74.61% in 2026.
- Amphastar Pharmaceuticals' Profit After Tax stood at $35.1 million in 2022, then climbed by 8.71% to $38.1 million in 2023, then dropped by 1.98% to $37.4 million in 2024, then slumped by 34.67% to $24.4 million in 2025, then slumped by 73.72% to $6.4 million in 2026.
- Business Quant data shows AMPH's Profit After Tax at $6.4 million in Q1 2026, $24.4 million in Q4 2025, and $17.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 935.73 Mn | 645.60 Mn | 93.47 Mn | 30.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.35 Mn |
| Mar 31, 2026 | 6.42 Mn |
| Dec 31, 2025 | 24.43 Mn |
| Sep 30, 2025 | 17.35 Mn |
| Jun 30, 2025 | 31.03 Mn |
| Mar 31, 2025 | 25.29 Mn |
| Dec 31, 2024 | 37.39 Mn |
| Sep 30, 2024 | 40.43 Mn |
| Jun 30, 2024 | 37.95 Mn |
| Mar 31, 2024 | 43.18 Mn |
| Dec 31, 2023 | 38.15 Mn |
| Sep 30, 2023 | 49.61 Mn |
| Jun 30, 2023 | 26.12 Mn |
| Mar 31, 2023 | 26.03 Mn |
| Dec 31, 2022 | 35.09 Mn |
| Sep 30, 2022 | 15.87 Mn |
| Jun 30, 2022 | 17.35 Mn |
| Mar 31, 2022 | 24.25 Mn |
| Dec 31, 2021 | 19.76 Mn |
| Sep 30, 2021 | 30.96 Mn |